NEW YORK (TheStreet) -- Clorox
(CLX) shares are up 1.1% to $87.60 on Friday following the release of the company's fourth quarter earnings results.
The company reported a 7% decline in profit to $170 million, or $1.40 cents per diluted share, 5 cents better than analyst expectations.
Revenue for the quarter was down 2% from the year ago period to $1.51 billion, slightly ahead of analysts expectations of $1.50 billion.
Must Read: Warren Buffett's 25 Favorite Stocks
TheStreet Ratings team rates CLOROX CO/DE as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:"We rate CLOROX CO/DE (CLX) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its increase in net income, notable return on equity, good cash flow from operations, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated."
CLX data by YCharts
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts